|
DDX50 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.17069695551686E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.45219999650948E-09 |
| Normal-vs-Stage2 |
4.49640000010909E-07 |
| Normal-vs-Stage3 |
2.90389934320956E-11 |
| Normal-vs-Stage4 |
5.87989990030735E-10 |
| Stage1-vs-Stage2 |
4.913400E-01 |
| Stage1-vs-Stage3 |
9.598400E-02 |
| Stage1-vs-Stage4 |
6.939600E-02 |
| Stage2-vs-Stage3 |
6.198400E-01 |
| Stage2-vs-Stage4 |
4.837600E-01 |
| Stage3-vs-Stage4 |
7.536400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.5958792327383E-12 |
| Normal-vs-AfricanAmerican |
6.235600E-03 |
| Normal-vs-Asian |
1.19309999990769E-07 |
| Caucasian-vs-AfricanAmerican |
7.376000E-02 |
| Caucasian-vs-Asian |
6.878200E-01 |
| AfricanAmerican-vs-Asian |
1.598440E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.00120023382999E-10 |
| Normal-vs-Female |
2.55020005113238E-10 |
| Male-vs-Female |
2.637800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.39169999547573E-08 |
| Normal-vs-Age(41-60Yrs) |
5.3412052558599E-11 |
| Normal-vs-Age(61-80Yrs) |
4.82149986602565E-10 |
| Normal-vs-Age(81-100Yrs) |
2.881000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.527610E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.312800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.871600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.881800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.643000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.669600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.556800E-03 |
| Classical-VS-Follicular |
2.194600E-01 |
| Classical-VS-Other |
5.516400E-01 |
| Classical-VS-Normal |
8.76280048522915E-10 |
| Tall-VS-Follicular |
1.127370E-01 |
| Tall-VS-Other |
6.233400E-01 |
| Tall-VS-Normal |
9.6890995227028E-10 |
| Follicular-VS-Other |
9.359400E-01 |
| Follicular-VS-Normal |
1.45799999962115E-07 |
| Other-VS-Normal |
7.416200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.15479983750799E-10 |
| Normal-vs-N1 |
4.72649697158545E-11 |
| N0-vs-N1 |
2.988200E-02 |
|
|
